Stay updated on PSCA-Targeted CAR-T in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PSCA-Targeted CAR-T in Solid Tumors Clinical Trial page.

Latest updates to the PSCA-Targeted CAR-T in Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.5.3 is now shown on the page, replacing the previous version tag. This indicates a minor metadata update to the study record without changes to the main content.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed. This reflects an internal version update to the study record with no user-facing content changes indicated.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check75 days agoChange DetectedStatus updated to Terminated; sponsor information updated to Regeneron Pharmaceuticals with Bellicum as a former sponsor, and related dates and investigator fields adjusted.SummaryDifference1%

- Check89 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding–related operating status notice; no changes to the study details or data.SummaryDifference0.4%

Stay in the know with updates to PSCA-Targeted CAR-T in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PSCA-Targeted CAR-T in Solid Tumors Clinical Trial page.